[go: up one dir, main page]

WO1997007812A1 - Procede de preparation de compositions pharmaceutiques ecologiques du domaine veterinaire - Google Patents

Procede de preparation de compositions pharmaceutiques ecologiques du domaine veterinaire Download PDF

Info

Publication number
WO1997007812A1
WO1997007812A1 PCT/MK1995/000001 MK9500001W WO9707812A1 WO 1997007812 A1 WO1997007812 A1 WO 1997007812A1 MK 9500001 W MK9500001 W MK 9500001W WO 9707812 A1 WO9707812 A1 WO 9707812A1
Authority
WO
WIPO (PCT)
Prior art keywords
procedure
obtaining
oils
ethers
mixing under
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/MK1995/000001
Other languages
English (en)
Inventor
Jasna Mandic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU42725/96A priority Critical patent/AU4272596A/en
Publication of WO1997007812A1 publication Critical patent/WO1997007812A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)

Definitions

  • This request for patent is concerning of the production process i.e. the procedure for obtaining an ecological pharmaceutical com ⁇ positions applicated in veterinary medical field that means that this invention is 5 related with the field of medicine and pharmacology. Because of the fact that this invention is concerning of the applica ⁇ tion of the active substances from organic origins used during the process of production of this medicaments, according to " Interna ⁇ tional patent classification " , this invention could be classified in o the clss with classification number A6K31. Technical problems solved with this invention
  • the technical problem that is solved with this invention is the obtainment of various types of veterinary medicaments on the ba ⁇ sis of natural components, that successfully replace prior art prod- 5 ucts based on sulfonamides and antibiotics.
  • the application of the active substances according to the invention eliminates many un ⁇ wanted effects caused by the prior art sulfonamides and antibiot ⁇ ics, such as:
  • the medicaments based on the active components are ecological, and besides of that are not uretogenic and teratogenic and are in correlation with a new tendency in the 5 environmentprotection.
  • the primary component which is apphed in the pharmaceutical com ⁇ positions according to the invention is ethers oil obtained from any of the following plants: -ORIGANUM VULGARIS ( different variety )
  • the residue of the leaves and blossoms is used to extract tannin.
  • the substances which are used in the procedure for preparing the product are:
  • the three types of oils are mixed in the given percent ⁇ age.
  • the mixture is than blended together in a mixer with 30 % of the lactose at a speed of 200 rotations per minute for a period of 10 minutes.
  • the rest of the lactose is added and mixed again.
  • the mixture is then put in capsules.
  • the procedure for making the paste goes as follows: the vaselinum album is placed in the mixer together with 20 % of the total contents and heated up to a temperature of 50 °C . The heated mass is then added to the mixture of above-mentioned quantities of oil and the product is mixed together for 5 minutes at a speed of 100 rotations per minute. At the end the parafinum liquidum is added and the product is packed.
  • the substances which are used in the procedure for the prepa ⁇ ration ofthe product are:
  • the substance used in the procedure for preparing the product are:
  • the substances used in the procedure for preparing the prod ⁇ uct are: - MEDICAL POWDER 92-94 %

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne l'obtention de principes actifs à partir de quelques variétés de plantes, telles que Origanum vulgaris, Thymus vulgaris, Salvia officialis, Mentha piperita. Le procédé consiste à obtenir, par distillation de parties séchées de la plante les huiles d'éther, tout en obtenant par extraction le tanin. Ces huiles d'éther sont utilisées pour le procédé d'obtention de différentes sortes de médicaments permettant de soigner plusieurs affections animales, telles que la colibacillose, la coccidose, la mastite ou des lésions, entre autres.
PCT/MK1995/000001 1995-08-25 1995-12-14 Procede de preparation de compositions pharmaceutiques ecologiques du domaine veterinaire Ceased WO1997007812A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU42725/96A AU4272596A (en) 1995-08-25 1995-12-14 Production process of the ecological pharmaceutical compositions in the veterinary medical field

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MK950076 1995-08-25
MK7695 1995-08-25

Publications (1)

Publication Number Publication Date
WO1997007812A1 true WO1997007812A1 (fr) 1997-03-06

Family

ID=19740111

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MK1995/000001 Ceased WO1997007812A1 (fr) 1995-08-25 1995-12-14 Procede de preparation de compositions pharmaceutiques ecologiques du domaine veterinaire

Country Status (2)

Country Link
AU (1) AU4272596A (fr)
WO (1) WO1997007812A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794024A1 (fr) * 1999-05-28 2000-12-01 Ecopsi Preparation a base de tanin(s) destinee au traitement de la coccidiose
EP4011385A1 (fr) * 2020-12-07 2022-06-15 Diko Holger Becker Substance active poue traitement des mammites

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424534A1 (fr) * 1989-04-28 1991-05-02 DERYABIN, Alexandr Mikhailovich Preparation pharmaceutique de traitement de la mastite chez l'animal et chez l'homme
JPH06166626A (ja) * 1992-05-12 1994-06-14 Taiyo Kagaku Co Ltd 生菌粉末
JPH06256180A (ja) * 1993-03-04 1994-09-13 Taiyo Kagaku Co Ltd 腸内環境改善組成物
FR2706770A1 (en) * 1993-06-21 1994-12-30 Pelletier Jacques Formula for the treatment of tuberculosis.
JPH07305089A (ja) * 1994-05-10 1995-11-21 Pola Chem Ind Inc 発想促進剤

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424534A1 (fr) * 1989-04-28 1991-05-02 DERYABIN, Alexandr Mikhailovich Preparation pharmaceutique de traitement de la mastite chez l'animal et chez l'homme
JPH06166626A (ja) * 1992-05-12 1994-06-14 Taiyo Kagaku Co Ltd 生菌粉末
JPH06256180A (ja) * 1993-03-04 1994-09-13 Taiyo Kagaku Co Ltd 腸内環境改善組成物
FR2706770A1 (en) * 1993-06-21 1994-12-30 Pelletier Jacques Formula for the treatment of tuberculosis.
JPH07305089A (ja) * 1994-05-10 1995-11-21 Pola Chem Ind Inc 発想促進剤

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 9428, Derwent World Patents Index; Class B04, AN 94-230621, XP002006855 *
DATABASE WPI Section Ch Week 9441, Derwent World Patents Index; Class B04, AN 94-329918, XP002006854 *
DATABASE WPI Section Ch Week 9604, Derwent World Patents Index; Class B04, AN 96-036108, XP002006030 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794024A1 (fr) * 1999-05-28 2000-12-01 Ecopsi Preparation a base de tanin(s) destinee au traitement de la coccidiose
WO2000072858A1 (fr) * 1999-05-28 2000-12-07 Ecopsi Composition d'additif alimentaire destine au traitement preventif de la coccidiose
EP4011385A1 (fr) * 2020-12-07 2022-06-15 Diko Holger Becker Substance active poue traitement des mammites

Also Published As

Publication number Publication date
AU4272596A (en) 1997-03-19

Similar Documents

Publication Publication Date Title
AU2018397667A1 (en) Compositions containing thymohydroquinone and their method of preparation
WO1997007812A1 (fr) Procede de preparation de compositions pharmaceutiques ecologiques du domaine veterinaire
CN109498605A (zh) 一种治疗妇科炎症的组合物及其在外用组合物中的应用
WO2022035772A1 (fr) Formulations de cannabinoïdes pour des sujets vétérinaires ou humains
CN1172598C (zh) 大蒜精油灭菌杀虫乳液及其工艺
KR20130130034A (ko) 몰약의 신규 용도로서 폐경기 증상의 치료
EP1084708B1 (fr) Procede de transformation d'une solution medicinale a base de plantes naturelles en medicament sous forme de poudre
CN107485648A (zh) 猴桃标白猴薄荷油外用组合物及其制备方法
US4528192A (en) Process for preparing an antitoxic composition
Singh et al. Design and formulation of Tridax procumbens based polyherbal cream for wound healing potential
CN109820884B (zh) 具有健胃作用的复合木香油自乳化软胶囊及制备方法与应用
RU2116083C1 (ru) Способ получения иммуноглобулинового препарата с рекомбинантным альфа-2-интерфероном
CN108042483A (zh) 硝酸咪康唑乳膏及其制备方法
CN100375616C (zh) 一种以战骨为原料的健骨滴丸及其制备方法
CN108201516A (zh) 一种玫瑰保养乳房按摩精油及其制备方法
RU2116067C1 (ru) Препарат,содержащий эфирное или терпентинное масло, и способ его получения
bin Hasnadi et al. Evaluation of peppermint based menthol as a cooling agent for development of hydrogel cooling patch
CN1072933C (zh) 一种驱治牲畜体内寄生虫的阿苯达唑混悬液及其制备方法
CN101129347A (zh) 氟苯尼考油乳注射液及配制方法
RU2089205C1 (ru) Фармацевтический препарат и способ его изготовления
Banga et al. EXPLORING SNEHA KALPANA: A COMPREHENSIVE ANALYSIS IN AYURVEDIC PRACTICE
RU2086250C1 (ru) Фармацевтический препарат и способ его получения
Parsons Hypertrophy of the Turbinate.
CN107929173A (zh) 荞艾茶籽精油及其制备方法
DE2450107A1 (de) Vaginalring

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AU BB BG BR BY CA CN CZ EE FI GE HU IS JP KG KP KR KZ LK LR LT LV MD MG MN MX NO NZ PL RO RU SG SI SK TJ TM TT UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase